Literature DB >> 18561890

A review of the neuropharmacological properties of khat.

Anteneh M Feyissa1, John P Kelly.   

Abstract

BACKGROUND: The psychostimulant khat (Catha edulis Forsk), is a herbal drug cultivated and chewed as a recreational and socializing drug in East Africa and the Arabian Peninsula for centuries. Due to increasing air transportation and the loosening of customs restrictions, it is now readily available in the Western Countries mainly used by immigrants from khat growing areas causing a concern to policy-makers.
OBJECTIVE: We conducted this review to further gain an insight to the neuropharmacological effects of khat.
METHODOLOGY: PubMed search engine with key terms 'khat' or 'qat' or 'mirra' or'qaad/jaad' or 'cathinone' was used to obtain articles relevant to khat chewing. In total 284 English written articles published from 1959 to 2007 were screened.
RESULTS: Most of the studies focused on cathinone, the postulated active psychostimulant alkaloid in khat. There were few studies which investigated the entire plant extract in either in vitro or animal studies. In the majority of the studies it was reported that both cathinone and cathine, another psychoactive constituent, have actions that are similar to those of amphetamine.
CONCLUSIONS: It seems that the well investigated khat alkaloids have many features similar to amphetamines; however there is a need for a more thorough examination of khat itself in well designed in vitro, animal and human studies with a range of comparator drugs before confirming the claim that khat is a "natural amphetamine".

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18561890     DOI: 10.1016/j.pnpbp.2007.12.033

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  44 in total

1.  Poor working memory and reduced blood pressure levels in concurrent users of khat and tobacco.

Authors:  Motohiro Nakajima; Richard Hoffman; Mustafa Al'Absi
Journal:  Nicotine Tob Res       Date:  2013-09-28       Impact factor: 4.244

2.  Psychoses, PTSD, and depression in Somali refugees in Minnesota.

Authors:  Jerome Kroll; Ahmed Ismail Yusuf; Koji Fujiwara
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-03-31       Impact factor: 4.328

3.  Correlates of Concurrent Khat and Tobacco Use in Yemen.

Authors:  Motohiro Nakajima; Anisa Dokam; Najat Saem Khalil; Mohammed Alsoofi; Mustafa al'Absi
Journal:  Subst Use Misuse       Date:  2016-08-03       Impact factor: 2.164

4.  Mephedrone, an abused psychoactive component of 'bath salts' and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum.

Authors:  Mariana Angoa-Pérez; Michael J Kane; Dina M Francescutti; Katherine E Sykes; Mrudang M Shah; Abiy M Mohammed; David M Thomas; Donald M Kuhn
Journal:  J Neurochem       Date:  2012-02-09       Impact factor: 5.372

Review 5.  Khat use and neurobehavioral functions: suggestions for future studies.

Authors:  Richard Hoffman; Mustafa Al'Absi
Journal:  J Ethnopharmacol       Date:  2010-05-27       Impact factor: 4.360

6.  Olanzapine and pulmonary embolism, a rare association: a case report.

Authors:  Julian Fz Maempel; Geraldine Darmanin; Kashif Naeem; Mehool Patel
Journal:  Cases J       Date:  2010-01-22

7.  Differential effects of cathinone compounds and MDMA on body temperature in the rat, and pharmacological characterization of mephedrone-induced hypothermia.

Authors:  S E Shortall; A R Green; K M Swift; K C F Fone; M V King
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

Review 8.  Khat - a controversial plant.

Authors:  Erica E Balint; George Falkay; Gabor A Balint
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

9.  Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA.

Authors:  Mariana Angoa-Pérez; Michael J Kane; Denise I Briggs; Dina M Francescutti; Catherine E Sykes; Mrudang M Shah; David M Thomas; Donald M Kuhn
Journal:  J Neurochem       Date:  2013-01-08       Impact factor: 5.372

10.  Developmental outcomes of 3,4-methylenedioxymethamphetamine (ecstasy)-exposed infants in the UK.

Authors:  Lynn T Singer; Derek G Moore; Meeyoung O Min; Julia Goodwin; John J D Turner; Sarah Fulton; Andrew C Parrott
Journal:  Hum Psychopharmacol       Date:  2015-07       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.